“Most favored nation” pricing model for certain drugs 

According to a recent poll, three in four adults in the United States say the cost of medications is unaffordable. With drug prices in the U.S. higher than in other countries as much as 10 times, President Trump is expected to sign an executive order next week instructing federal health officials to adopt a “most favored nation” pricing model for certain drugs covered by Medicare. However, President Trump tried to implement a similar policy in 2020, but failed due to a lawsuit filed in federal court by the drug industry. Berkeley Lovelace, Jr., reporting for NBC News on how this executive order may push drugmakers to charge the same prices as other countries. Read Mr. Lovelace’s article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.